These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16116155)

  • 1. First Amsterdam, then Bethesda, now Melbourne?
    Lenz HJ
    J Clin Oncol; 2005 Sep; 23(27):6445-9. PubMed ID: 16116155
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular screening for the Lynch syndrome--better than family history?
    Lynch HT; Lynch PM
    N Engl J Med; 2005 May; 352(18):1920-2. PubMed ID: 15872208
    [No Abstract]   [Full Text] [Related]  

  • 3. Microsatellite instability.
    de la Chapelle A
    N Engl J Med; 2003 Jul; 349(3):209-10. PubMed ID: 12867603
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer: predicting prognosis for patients and probands using immunohistochemistry.
    Khurana V; Stollman N; Rogers AI
    Am J Gastroenterol; 2000 Oct; 95(10):2981-2. PubMed ID: 11051382
    [No Abstract]   [Full Text] [Related]  

  • 6. Current applications of genetic technology in predisposition testing and microsatellite instability assays.
    Frazier ML; Su LK; Amos CI; Lynch PM
    J Clin Oncol; 2000 Nov; 18(21 Suppl):70S-4S. PubMed ID: 11060331
    [No Abstract]   [Full Text] [Related]  

  • 7. On the advent of MSI testing of all colorectal cancers and a substantial part of other Lynch syndrome-related neoplasms.
    Dinjens WN; van Leerdam ME; Wagner A
    Expert Rev Mol Diagn; 2010 May; 10(4):381-4. PubMed ID: 20465492
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
    Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of colorectal cancer. Foreword.
    Axon AT
    Gastrointest Endosc; 2008 Oct; 68(4 Suppl):S2. PubMed ID: 18805237
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary non-polyposis colon cancer.
    Devlin LA; Price JH; Morrison PJ
    Ulster Med J; 2005 May; 74(1):14-21. PubMed ID: 16025587
    [No Abstract]   [Full Text] [Related]  

  • 12. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population.
    Terdiman JP
    Gastroenterology; 2005 Aug; 129(2):741-4. PubMed ID: 16083727
    [No Abstract]   [Full Text] [Related]  

  • 13. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Macrae F; Harris M
    J Natl Cancer Inst; 2005 Jun; 97(12):936-7; author reply 937-8. PubMed ID: 15956656
    [No Abstract]   [Full Text] [Related]  

  • 15. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
    Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
    Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing for inherited susceptibility of colorectal cancer: part II. Hereditary nonpolyposis colorectal cancer (HNPCC).
    Tecnologica MAP Suppl; 1998 Feb; ():10-5. PubMed ID: 10183352
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing.
    Gruber SB
    Gastroenterology; 2006 Feb; 130(2):577-87. PubMed ID: 16472609
    [No Abstract]   [Full Text] [Related]  

  • 19. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in colorectal cancer.
    Heinimann K; Müller H; Dobbie Z
    N Engl J Med; 2000 May; 342(21):1607-8. PubMed ID: 10841678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.